Skip to main content
Premium Trial:

Request an Annual Quote

Robin Stears, Kevin Shutes, Robert Joss, Bernice Welles, Michael Sweeney, Arnold Oronsky, Gil Kliman

Premium

Robin Stears joins BioRad Laboratories of Hercules, Calif., as marketing manager, microarray business unit. Previously, Stears was senior scientist for Arrayit, the biotechnology division of TeleChem International of Sunnyvale, Calif. She also served as a microarray industry consultant to the healthcare division of Gerson Lehrman Group. Previously, Stears directed the gene expression profiling group for Adventis Pharmaceuticals. Stears holds PhD and BS degrees from the State University of New York at Stony Brook.

 

Kevin Shutes, previously the general manager, has been named president of the Celex wire and tube-cutting division of Point Technologies of Boulder, Colo., the company said last week. Celex manufactures Point Technologies microarray spotting pins.

 

Robert Joss, dean of the Graduate School of Business at Stanford University, has been named to the board of directors of Agilent Technologies, the company said last week. Before joining Stanford in 1999, Joss was chief executive officer and managing director of Westpac Banking, Australia’s second largest bank. Joss, 62, earned his MBA and PhD at Stanford University. He holds a BA in economics from the University of Washington.

 

Bernice Welles joins the San Francisco office of MPM BioVentures, the venture capital subsidiary of MPM Capital, which manages some $2.1 billion in capital, as a venture partner. She most recently served as vice president of product development at Genentech.

 

Michael Sweeney has been promoted to general partner of the VC firm InterWest Partners, and will co-lead the firm’s life sciences team with other general partners Arnold Oronsky and Gil Kliman, InterWest said July 15. Sweeney has been a venture partner at InterWest since 2001, and was entrepeneur in residence at the Menlo Park, Calif., and Dallas-based firm from 1998 to 2001. Prior to that, Sweeney developed anti-arrhythmia cardiac devices and founded two companies, Ventritex and Epicor Medical. Currently, Sweeney represents microfluidics company Fluidigm, which InterWest has backed, among other companies.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.